S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

LEXXW Lexaria Bioscience Corporation

0.75

0.14 (22.95%)

Jan 10 2025 - Closed

Delayed by 15 minutes

Form 424B3 - Prospectus [Rule 424(b)(3)]

null

Lexaria Bioscience (NASDAQ:LEXXW)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Lexaria Bioscience Charts.

Lexaria Bioscience (NASDAQ:LEXXW)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Lexaria Bioscience Charts.

Lexaria Bioscience Corporation News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 10 January 2025 (6 hours ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Monday 6 January 2025 (4 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 3 January 2025 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 18 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Tuesday 17 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Monday 16 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Thursday 5 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 26 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 18 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 16 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 2 October 2024 (3 months ago) • Edgar (US Regulatory)

More Lexaria Bioscience Corporation News Articles

North Bay Resources (PK)

Mullen Automotive

Impact Fusion (PK)

Lightwave Logic

Intergrated Cannabis Sol... (PK)

Rennova Health (CE)

RespireRx Pharmaceuticals (CE)

Moon Equity (PK)

GBT Technologies (PK)

Valiant Eagle (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions